• Liraglutide drug associated with lower risk of cardiovascular events

    3 days ago - By News Medical

    Real world data from a large Nordic study shows that use of liraglutide, a drug for type 2 diabetes, is associated with a lower risk of myocardial infarction, stroke or cardiovascular death.
    Read more ...

     

  • Liver disease common in children with type 2 diabetes

    3 days ago - By Healio

    An analysis of data from a small cohort of children with type 2 diabetes and nonalcoholic fatty liver disease, or NAFLD, suggests that nonalcoholic steatohepatitis, or NASH, is common among these patients, with 26% showing signs of advanced fibrosis, according to findings published in Pediatric Diabetes.
    “Understanding the relationship between type 2 diabetes and NAFLD in children is particularly important, as type 2 diabetes has been strongly associated with liver-related mortality in adult patients with NAFLD,” Ron S. Newfield, MD, a pediatric endocrinologist with the University
    Read more ...

     

  • Liraglutide Lowers the Risk of Cardiovascular Events

    Liraglutide Lowers the Risk of Cardiovascular Events

    3 days ago - By Medindia Health

    Liraglutide, the glucagon-like peptide analogue used for type 2 diabetes, found to decrease the risk of various cardiovascular events especially among patients with high risk
    Read more ...

     

  • New therapeutic strategy is emerging for type 2 diabetes

    3 days ago - By News Medical

    Diabetes is a disease in which blood sugar levels are high over a prolonged period. In the case of type 2 diabetes, this phenomenon which is caused by a disruption of the glucose metabolism develops progressively and insidiously.
    Read more ...